Banning mRNA technology in response to the many missteps of public health officials during the pandemic is a textbook example ...

Kennedy won Senate confirmation to his job, in part, by promising not to change the nation’s vaccine schedule. Since taking ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

With that in mind, let's consider two stocks down 17% and 36%, respectively, this year that are worth investing in right now: ...

RNA-based technologies are a powerful molecular biology toolbox, empowering scientists to decipher the complexities of living ...

says Siow Ming Lee, a medical oncologist at University College London, who is leading a clinical trial of an mRNA vaccine for lung cancer patients.

Moderna faces challenges with respiratory vaccine sales and strong competition. Click here to read an analysis of MRNA stock ...

In the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) was a top performer, from both a share-price and an ...

“She’s an example of this emerging face of cancer that's really quite challenging and quite alarming,” Deignan said.

A scientific revolution is underway as researchers push to bring atomic-level precision, once reserved for small molecule ...

Experimental mRNA Cancer Vaccine Shows Potential for Advanced Stage Cancer Patients in Phase 1 Trial Sep. 13, 2024 — Interim data from the Phase I dose escalation part of the mRNA cancer ...